Holtz Biopharma Consulting was formed in 2003. Since then the organization and collaborators have completed a number of significant projects in biotechnology and biomanufacturing. The principal consultant is R. Barry Holtz, Ph.D., a 35 year veteran of the biotechnology business primarily in the California Bay Area and now in Texas.
Our ramp up process is designed to empower your team and outfit them with the tools they need to succeed. Talk to us today about how we can support your growth, limit your turnover, and put you on a solid track to success and profit.
Dr. Holtz is the principal of Holtz Biopharma Consulting. He consults for pharma and bio-pharma companies in biologic therapeutics development, bioprocess design and facilities design and engineering. Dr. Holtz was the co-founder and Chief Science and Technology Officer for G-CON Manufacturing, manufacturers of autonomous bioprocess facilities and Caliber Biotherapeutics and manufacturer of protein therapeutics using plants as bioreactors. Dr. Holtz recently served as President of iBio CDMO (Caliber was sold to iBio in 2016).
Dr. Holtz was also a co-founder and CEO of InterveXion Therapeutics from 2004-2015. InterveXion develops antibodies to combat drug abuse and its lead candidate for methamphetamine abuse is in clinical trials.
Prior to the founding G-CON, LLC, Dr. Holtz was the Senior Vice President of Biopharmaceutical Development for Large Scale Biology Corporation for 15 years and was an integral member of the management team that took the company from a start-up to a successful public company. Dr. Holtz was responsible for the product development, manufacturing, and clinical trials of new protein therapeutics.
Dr. Holtz was the founder and President of Holtz Bio-Engineering in 1981. Holtz Bio-Engineering was a biotech pioneer in the design of bioreactors and digital control systems.
Dr. Holtz has held research management positions at Foremost-Mckesson and was on the faculty of Ohio State University. He received his Ph.D. at Pennsylvania State University and was an NSF Postdoctoral Biochemist Fellow at Scripps Institution of Oceanography. Dr. Holtz has been awarded 24 US patents and has published over 65 scientific papers. Dr. Holtz was awarded the Pennsylvania State University, Outstanding Alumni Award in 2003.